Purple Biotech Ltd. (PPBT) Earnings History
Net Loss13 years of earnings data (2013–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Purple Biotech Ltd. (PPBT) Earnings Overview
As of June 30, 2026, Purple Biotech Ltd. (PPBT) reported trailing twelve-month net income of -$26M, reflecting -24967.9% year-over-year growth. The company earned $-5637.08 per diluted share over the past four quarters.
Looking at the long-term picture, PPBT's historical earnings data spans multiple years. The company achieved its highest annual net income of -$19,880 in fiscal 2023.
Purple Biotech Ltd. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including IMVT (-$506M net income), KYMR (-$315M net income, -794.4% margin), AGEN ($65M net income, 0.1% margin), PPBT has comparable earnings metrics. Compare PPBT vs IMVT →
PPBT Earnings vs Peers
Earnings metrics vs comparable public companies
PPBT Historical Earnings Data (2013–2025)
13 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$26M | -264.4% | -$27M | $-11080.00 | - | - |
| 2024 | -$7M | -36318.5% | -$11M | $-44.20 | - | - |
| 2023 | $-19,880 | +99.9% | -$22M | $-180.00 | -10.2% | -11374.1% |
| 2022 | -$22M | -17.9% | -$23M | $-240.00 | - | - |
| 2021 | -$18M | +34.3% | -$18M | $-200.00 | - | - |
| 2020 | -$28M | -378.6% | -$13M | $-500.00 | -2799.9% | -1323.9% |
| 2019 | -$6M | -12.5% | -$7M | $-560.00 | -585.0% | -715.6% |
| 2018 | -$5M | +57.3% | -$8M | $-740.00 | -520.0% | -782.6% |
| 2017 | -$12M | -0.4% | -$12M | $-2580.00 | -12177.0% | -11966.0% |
| 2016 | -$12M | -188.6% | -$7M | $-4220.00 | - | - |
| 2015 | -$4M | +20.0% | -$4M | $-8740.00 | - | - |
| 2014 | -$5M | -99.8% | -$5M | $-46880.00 | - | - |
| 2013 | -$3M | - | -$3M | $-64060.00 | - | - |
Download Data
Export PPBT earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
13+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
PPBT — Frequently Asked Questions
Quick answers to the most common questions about buying PPBT stock.
What is PPBT earnings per share (EPS)?
PPBT trailing twelve-month (TTM) diluted EPS is $-5637.08, reflecting -24967.9% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2013 to 2025 is available in the table on this page.
What is Purple Biotech Ltd.'s net income?
Purple Biotech Ltd. (PPBT) trailing twelve-month net income is $-26M as of 2025. Earnings declined -24967.9% year-over-year.
Is PPBT profitable?
PPBT is not currently profitable on a TTM basis, reporting a net loss of $-26M. Net margin is N/A. Investors should monitor for a return to profitability.
What is PPBT's earnings growth rate?
PPBT compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2013 to 2025.
What are PPBT's profit margins?
Purple Biotech Ltd. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -124.0%.
Is PPBT growing earnings?
PPBT earnings are declining — EPS fell -24967.9% year-over-year. TTM net income dropped to $-26M. This contrasts with the 5-year CAGR of N/A.
What was PPBT's best earnings year?
Purple Biotech Ltd.'s highest annual net income on record is $-19880.00, achieved in fiscal year 2023. Earnings history on this page spans 2013 to 2025 and includes all annual and quarterly figures.
What were PPBT's earnings last quarter?
PPBT's most recent reported quarter was Q1 2026. Net income was $-86000.00 with diluted EPS of $-19.94. For a full breakdown of all quarters, see the quarterly earnings table on this page.